FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 02/20/2019 |
3. Issuer Name and Ticker or Trading Symbol
Horizon Pharma plc [ HZNP ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 101,960 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Employee stock options (right to buy) | (1) | 06/07/2022 | Ordinary Shares | 20,000 | $3.95 | D | |
Employee stock options (right to buy) | (1) | 01/01/2024 | Ordinary Shares | 18,000 | $7.61 | D | |
Employee stock options (right to buy) | (2) | 03/22/2025 | Ordinary Shares | 53,666 | $22.14 | D | |
Restricted Stock Units | (3) | (3) | Ordinary Shares | 6,500 | $0.00 | D | |
Restricted Stock Units | (4) | (4) | Ordinary Shares | 20,000 | $0.00 | D | |
Restricted Stock Units | (5) | (5) | Ordinary Shares | 15,000 | $0.00 | D | |
Restricted Stock Units | (6) | (6) | Ordinary Shares | 13,400 | $0.00 | D | |
Restricted Stock Units | (7) | (7) | Ordinary Shares | 24,521 | $0.00 | D |
Explanation of Responses: |
1. Fully vested |
2. 25% of the shares subject to the option vested and become exercisable on March 23, 2016 and the remaining shares vest in 36 equal monthly installments thereafter. |
3. The RSU's vest 1/4th annually on each anniversary of March 23, 2015. |
4. The RSU's vest 50% annually on each anniversary of August 1, 2017. |
5. The RSU's vest 1/3rd annually on each anniversary of June 10, 2018. |
6. The RSU's vest 1/3rd annually on each anniversary of January 5, 2018. |
7. The RSU's vest 1/3rd annually on each anniversary of January 5, 2019. |
Remarks: |
Officer Title: SVP, Head of Medical Affairs & Outcomes Research. |
/s/ Miles McHugh, Attorney-in-fact | 02/26/2019 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |